Pain in Parkinson's disease

scientific article published on 23 September 2011

Pain in Parkinson's disease is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/MDS.23959
P698PubMed publication ID21953990

P2093author name stringJoseph Jankovic
Ainhi D Ha
P433issue4
P921main subjectParkinson's diseaseQ11085
P304page(s)485-491
P577publication date2011-09-23
P1433published inMovement DisordersQ1486418
P1476titlePain in Parkinson's disease
P478volume27

Reverse relations

cites work (P2860)
Q41255139A clinical survey of pain in Parkinson's disease in Eastern China.
Q34408430A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson's disease
Q39985366A rare case of Parkinson's disease with severe neck pain owing to crowned dens syndrome
Q55386364Can therapeutic Thai massage improve upper limb muscle strength in Parkinson's disease? An objective randomized-controlled trial.
Q28066313Classification and Characteristics of Pain Associated with Parkinson's Disease
Q61882751Clinical Determinants of Parkinson's Disease-associated Pain Using the King's Parkinson's Disease Pain Scale
Q52449921Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review.
Q97643656D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice
Q64777581Defining Palliative Care Needs in Parkinson's Disease
Q28082795Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes
Q35156301Dopamine precursor depletion influences pain affect rather than pain sensation
Q50283049Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson's disease
Q39187047Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain
Q90231021Facial Pain Expression Recognition in Real-Time Videos
Q43222469Gingival pain: an unusual side effect of ziprasidone
Q35745128Influence of Dopaminergic Medication on Conditioned Pain Modulation in Parkinson's Disease Patients
Q38734712Integrated Approach for Pain Management in Parkinson Disease
Q33746794Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
Q37603968Loss of dopamine D1 receptors and diminished D1/5 receptor-mediated ERK phosphorylation in the periaqueductal gray after spinal cord lesion
Q38091653Management of motor and non-motor symptoms in Parkinson's disease
Q36135045Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects
Q26745618Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives
Q33552543Pain in Parkinson's disease associated with COMT gene polymorphisms
Q28067204Pain management in patients with Parkinson's disease: challenges and solutions
Q38003055Pains in Parkinson disease--many syndromes under one umbrella
Q49722384Palliative Care for Movement Disorders
Q80319319Parkinson disease: an update
Q36351543Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications
Q44402099Parkinson's disease patients with pain suffer from more severe non-motor symptoms
Q36503306Parkinson's disease related pain: a review of recent findings
Q38161787Pathophysiology of somatosensory abnormalities in Parkinson disease
Q92582900Physiotherapy for Parkinson's Disease in Sweden: Provision, Expertise, and Multi-professional Collaborations
Q41192353Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial
Q64780258Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease
Q58697526Revealing a novel nociceptive network that links the subthalamic nucleus to pain processing
Q33591471Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study
Q36595746Sensory aspects of movement disorders
Q92354761Sleep disturbances in Parkinson's disease are associated with central parkinsonian pain
Q90449474Symptom burden among individuals with Parkinson disease: A national survey
Q26828016The Rationale for Exercise in the Management of Pain in Parkinson's Disease
Q39186884The neuroprotective effects of caffeine in neurodegenerative diseases
Q91880841Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease
Q38194034Use of natural compounds in the management of diabetic peripheral neuropathy.

Search more.